Karin Wehlin
Vorstandsvorsitzender bei DIAGONAL BIO AB
Profil
Ms. Karin Wehlin is a Chief Executive Officer & Executive Director at Diagonal Bio AB.
She is on the Board of Directors at Diagonal Bio AB.
Ms. Wehlin was previously employed as a Co-Founder by EQL Pharma AB, a Chief Executive Officer by BoMill AB, a Chief Executive Officer by LU Food Science AB, and a Chief Executive Officer by Respiratorius AB.
She received her MBA from the University of Lund.
Aktive Positionen von Karin Wehlin
Unternehmen | Position | Beginn |
---|---|---|
DIAGONAL BIO AB | Vorstandsvorsitzender | 23.11.2023 |
Ehemalige bekannte Positionen von Karin Wehlin
Unternehmen | Position | Ende |
---|---|---|
BOMILL AB | Vorstandsvorsitzender | - |
Respiratorius AB
Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Vorstandsvorsitzender | - |
LU Food Science AB | Vorstandsvorsitzender | - |
EQL PHARMA AB | Gründer | - |
Ausbildung von Karin Wehlin
University of Lund | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
EQL PHARMA AB | Health Technology |
DIAGONAL BIO AB | Health Technology |
Health Technology | |
BOMILL AB | Technology Services |
Private Unternehmen | 1 |
---|---|
LU Food Science AB |